BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30519424)

  • 1. Complex gene expansion of the
    Feng P; Liu Z
    Ecol Evol; 2018 Nov; 8(22):11022-11030. PubMed ID: 30519424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-Genome Identification, Phylogeny, and Evolution of the Cytochrome P450 Family 2 (CYP2) Subfamilies in Birds.
    Almeida D; Maldonado E; Khan I; Silva L; Gilbert MT; Zhang G; Jarvis ED; O'Brien SJ; Johnson WE; Antunes A
    Genome Biol Evol; 2016 Apr; 8(4):1115-31. PubMed ID: 26979796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular evolution of the CYP2D subfamily in primates: purifying selection on substrate recognition sites without the frequent or long-tract gene conversion.
    Yasukochi Y; Satta Y
    Genome Biol Evol; 2015 Mar; 7(4):1053-67. PubMed ID: 25808902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
    Nakamura A; Yamamoto Y; Tasaki T; Sugimoto C; Masuda M; Kazusaka A; Fujita S
    Drug Metab Dispos; 1995 Nov; 23(11):1268-73. PubMed ID: 8591729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective deficiency of debrisoquine 4-hydroxylase activity in mouse liver microsomes.
    Masubuchi Y; Iwasa T; Hosokawa S; Suzuki T; Horie T; Imaoka S; Funae Y; Narimatsu S
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1435-41. PubMed ID: 9316857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of the CYP2D gene cluster in humans and four non-human primates.
    Yasukochi Y; Satta Y
    Genes Genet Syst; 2011; 86(2):109-16. PubMed ID: 21670550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phylogenetic and functional analysis of the vertebrate cytochrome p450 2 family.
    Kirischian N; McArthur AG; Jesuthasan C; Krattenmacher B; Wilson JY
    J Mol Evol; 2011 Jan; 72(1):56-71. PubMed ID: 21116621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional and cellular distribution of CYP2D subfamily members in rat brain.
    Miksys S; Rao Y; Sellers EM; Kwan M; Mendis D; Tyndale RF
    Xenobiotica; 2000 Jun; 30(6):547-64. PubMed ID: 10923858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ageing and cerebral serotonin deficit on the activity of cytochrome P450 2D (CYP2D) in the brain and liver of male rats.
    Haduch A; Pukło R; Alenina N; Nikiforuk A; Popik P; Bader M; Daniel WA
    Neurochem Int; 2020 Dec; 141():104884. PubMed ID: 33091481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat brain CYP2D activity alters in vivo central oxycodone metabolism, levels and resulting analgesia.
    McMillan DM; Miksys S; Tyndale RF
    Addict Biol; 2019 Mar; 24(2):228-238. PubMed ID: 29266563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversifying selection detected in only a minority of xenobiotic-metabolizing
    Chaney ME; Romine MG; Piontkivska H; Tosi AJ
    Xenobiotica; 2020 Dec; 50(12):1406-1412. PubMed ID: 32558606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of the Selective N-methyl-D-aspartate (NMDA) Receptor GluN2B Subunit Antagonist CP-101,606 on Cytochrome P450 2D (CYP2D) Expression and Activity in the Rat Liver and Brain.
    Haduch A; Bromek E; Pukło R; Jastrzębska J; Danek PJ; Daniel WA
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repression of multiple CYP2D genes in mouse primary hepatocytes with a single siRNA construct.
    Elraghy O; Baldwin WS
    In Vitro Cell Dev Biol Anim; 2015 Jan; 51(1):9-14. PubMed ID: 25124873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature.
    Nelson DR; Kamataki T; Waxman DJ; Guengerich FP; Estabrook RW; Feyereisen R; Gonzalez FJ; Coon MJ; Gunsalus IC; Gotoh O
    DNA Cell Biol; 1993; 12(1):1-51. PubMed ID: 7678494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo administration of H2 blockers, cimetidine and ranitidine, reduced the contents of the cytochrome P450IID (CYP2D) subfamily and their activities in rat liver microsomes.
    Orishiki M; Matsuo Y; Nishioka M; Ichikawa Y
    Int J Biochem; 1994 Jun; 26(6):751-8. PubMed ID: 8063004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducing rat brain CYP2D with nicotine increases the rate of codeine tolerance; predicting the rate of tolerance from acute analgesic response.
    McMillan DM; Tyndale RF
    Biochem Pharmacol; 2017 Dec; 145():158-168. PubMed ID: 28837793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endogenous substrates of brain CYP2D.
    Wang X; Li J; Dong G; Yue J
    Eur J Pharmacol; 2014 Feb; 724():211-8. PubMed ID: 24374199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cytochrome P450 2B sequence variation and gene copy number in facilitating dietary specialization in mammalian herbivores.
    Kitanovic S; Orr TJ; Spalink D; Cocke GB; Schramm K; Wilderman PR; Halpert JR; Dearing MD
    Mol Ecol; 2018 Feb; 27(3):723-736. PubMed ID: 29319892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunochemical detection of cytochrome P450 enzymes in liver microsomes of 27 cynomolgus monkeys.
    Uehara S; Murayama N; Nakanishi Y; Zeldin DC; Yamazaki H; Uno Y
    J Pharmacol Exp Ther; 2011 Nov; 339(2):654-61. PubMed ID: 21849623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarity in recombination rate and linkage disequilibrium at CYP2C and CYP2D cytochrome P450 gene regions among Europeans indicates signs of selection and no advantage of using tagSNPs in population isolates.
    Pimenoff VN; Laval G; Comas D; Palo JU; Gut I; Cann H; Excoffier L; Sajantila A
    Pharmacogenet Genomics; 2012 Dec; 22(12):846-57. PubMed ID: 23089684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.